​

HilleVax (HLVX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

HLVX Stock Forecast

HilleVax (HLVX) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $32.00, with a high of $34.00 and a low of $30.00. This represents a 1566.67% increase from the last price of $1.92.

- $7 $14 $21 $28 $35 High: $34 Avg: $32 Low: $30 Last Closed Price: $1.92

HLVX Stock Rating

HilleVax stock's rating consensus is Hold, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (16.67%), 5 Hold (83.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 6 0 5 1 Strong Sell Sell Hold Buy Strong Buy

HLVX Price Target Upside V Benchmarks

TypeNameUpside
StockHilleVax1566.67%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.92$1.92$1.92
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25--2--2
May, 25--2--2
Apr, 25--3--3
Mar, 25--4--4
Feb, 25--4--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 21, 2024Stephen WilleyStifel Nicolaus$34.00$15.87114.24%1670.83%
May 25, 2022David RisingerLeerink Partners$30.00$10.11196.74%1462.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 09, 2024H.C. WainwrightNeutraldowngrade
Jul 08, 2024GuggenheimBuyNeutraldowngrade
May 25, 2022SVB LeerinkOutperforminitialise
May 24, 2022GuggenheimBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.04$-3.00----
Avg Forecast$-3.01$-2.64$-1.92$-1.70$-1.46$-1.12
High Forecast$-2.96$-2.48$-1.56$-1.31$-1.40$-1.12
Low Forecast$-3.07$-2.84$-2.28$-2.29$-1.53$-1.12
Surprise %1.00%13.64%----

Revenue Forecast

$0 $10M $20M $30M $40M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast---$2.50M$47.12M$17.97M
High Forecast---$2.50M$47.12M$17.97M
Low Forecast---$2.50M$47.12M$17.97M
Surprise %------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.57M$-147.27M----
Avg Forecast$-123.57M$-107.99M$-77.95M$-73.12M$-59.48M$-45.34M
High Forecast$-120.29M$-100.68M$-63.17M$-53.21M$-56.84M$-45.34M
Low Forecast$-124.67M$-115.30M$-92.73M$-93.02M$-62.12M$-45.34M
Surprise %-36.37%----

HLVX Forecast FAQ

Is HilleVax stock a buy?

HilleVax stock has a consensus rating of Hold, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that HilleVax is a neutral investment for most analysts.

What is HilleVax's price target?

HilleVax's price target, set by 6 Wall Street analysts, averages $32 over the next 12 months. The price target range spans from $30 at the low end to $34 at the high end, suggesting a potential 1566.67% change from the previous closing price of $1.92.

How does HilleVax stock forecast compare to its benchmarks?

HilleVax's stock forecast shows a 1566.67% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for HilleVax over the past three months?

  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is HilleVax’s EPS forecast?

HilleVax's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.92, marking a -36.00% decrease from the reported $-3 in 2024. Estimates for the following years are $-1.7 in 2026, $-1.46 in 2027, and $-1.12 in 2028.

What is HilleVax’s revenue forecast?

HilleVax's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $2.5M, followed by $47.12M for 2027, and $17.97M for 2028.

What is HilleVax’s net income forecast?

HilleVax's net income forecast for the fiscal year ending in December 2025 stands at $-77.949M, representing a -47.07% decrease from the reported $-147M in 2024. Projections indicate $-73.12M in 2026, $-59.477M in 2027, and $-45.335M in 2028.